All filters
Slidesets
A Comparison of Single and Multiple Tablet Regiments for the Treatment of HCV Infection Among HIV Co-Infected Individuals | Astou Thiam
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Long-Term Changes of Liver Stiffness After the Use of All Oral DAA Regimens | Nicolás Merchante
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Follow-Up of Sustained Virologic Responders with Hepatitis C/HIV Coinfection and Advanced Liver Disease | C. Soeiro
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
HBV managment in HIV patients - Karine Lacombe, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Hepatitis C Diagnostic - Barrier to Effective Linkage to Care within Georgian Hepatitis C Elimination Program | Guranda Jikia, MD, MPH
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
HBV Novel Therapies- Maria Buti, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Decrease in HCV Coinfection in Individuals Newly Diagnosed with HIV-1 in Germany, January 2016 - December 2017 | Patrycja Machnowska
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Epidemiological Characteristics and Factors Contributing to the Development of Liver Fibrosis in HIV/HCV-Coinfected Patients in Ukraine | T. Kyrychenko
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Characterization of Patients Treated with Hepatitis C - is HIV a Burden? Analysis of an Individual Experience | C. Valente
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Debate: TDF vs. TAF in HBV management | Mark Nelson, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Debate: TDF vs. TAF in HBV management | Douglas Dieterich, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Case on HEV- Antonio Rivero-Juarez, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
NAFLD in HIV- infected patients- Juan Macías, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Failure Rate of Ultrasound Surveillance of Hepatocellular Carcinoma in HIV+ Patients | Nicolás Merchante
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
CD4-T Cell and Metabolic Changes adter DAAs: a Multicenter Study | L.A. Nicolini
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Expression of Immunological Markers in Inflammatory Infiltrate Cells of Liver in Patients with HIV/HIV Coinfection | N. Matsiyeuskaya
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Hapatitis C Reinfection after Sustained Virological Response in HIV/HCV Co-Infected Patients | Fábio Videira Santos
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
The role of Fibroscan: pre and post SVR- Nicolás Merchante, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective- Massimo Puoti, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective- Luz Martin-Carbonero, MD, PhD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
HAV in a Tertiary Hospital: 2017 Epidemic vs 2009-2016 Period | Andrea Lombardi, MD
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Management of DAA Failures - Gregory T. Everson, MD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016
Slidesets
Who Should We Treat? What is the “Point-of-No-Return”? - Norah Terrault, MD, MPH, FAASLD
Presented at:
Optimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016